Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Project

The Small Hydrophobic protein of Respiratory Syncytial Virus: a potential protein channel and a target for vaccination

Outputs and Outcomes

Code

3E015209

Duration

01 October 2009 → 30 September 2015

Funding

Regional and community funding: Special Research Fund, Research Foundation - Flanders (FWO)

Promotor

Xavier Saelens

Fellow

Bert Schepens

Research disciplines

Natural sciences
- Virology
- Genetics
Medical and health sciences
- Vaccinology
- Pathophysiology
- Adaptive immunology
- Molecular and cell biology not elsewhere classified

Keywords

therapy RSV Small Hydrophobic protein

Project description

Respiratory Syncytial virus (RSV) is an important human pathogen. There is only one prophylactic therapy available against RSV and there is no vaccine. In this project we will study the function of the small hydrophobic protein of RSV. In addition, we will evaluate if the RSV-SH protein is a candidate vaccine antigen.

English

Dutch

English

Cookie settings

In addition to functional cookies which are necessary for the website to function, Ghent University uses non-functional cookies such as statistical cookies and social media cookies. These non-functional cookies can also be placed by third parties, for example to measure the use of the site or to share content on social media. Certain media are only available if you accept the cookies. You can set and modify your cookie preferences yourself. Find out what cookies we use and why in the Cookie Statement.

Analytics

AnalyticsWe'll collect information about your visit to our site. It helps us understand how the site is used – what's working, what might be broken and what we should improve.

Powered by